Fresenius Kabi Deutschland GmbH, part of Fresenius SE & Co. KGaA, is a company headquartered in Bad Homburg vor der Hohe, Germany, that manufactures drugs in pharmaceutical preparations for human and veterinary use. The firm was founded in 1999. Steffen Roser, Christoph Funke and Tanja Greve are the current co-CEOs of the company.

Ed Geistlich S��hne AG F��r Chemische Industrie is a multi-national private company headquartered in Schlieren, Switzerland. The firm operates as holding company.

Fu Wai Hospital, founded in 1956.

The 301 Hospital (Chinese: 三〇一医院) or People's Liberation Army General Hospital (Chinese: 中国人民解放军总医院), which constitutes simultaneously the PLA Postgraduate Medical School (Chinese: 中国人民解放军医学院), located in Beijing, China, is a military hospital directly subsidiary to Logistic Support Department of the Central Military Commission and the largest general hospital under the auspices of the People's Liberation Army. Its mission includes assuring the health of PLA and China's leaders.

Omrix Biopharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets biological products for the biosurgical and immunotherapy markets.

FluidAI Medical is a Canadian company located in Kitchener, ON, that develops medical devices for detect gastrointestinal leaks after surgical procedures. The firm was founded in 2014 by Amr Abdelgawad and Youssef Helwa. Youssef Helwa has been the CEO since the company founding.\nThe company says this about itself: FluidAI Medical aims to create a paradigm shift in post-operative care, utilizing the plethora of data within the body, to help in the detection of post-operative complications at their onset. NERv's platform sensing technology augments existing wound drains and catheters, providing healthcare providers with a smart monitoring tool that can enhance the delivery of care. NERv's technology is being built with the goal of decreasing surgeon's response time to potential complications, making patient recovery easier, and hopefully saving lives.

Guangzhou Fuda Cancer Hospital is a tertiary specialized cancer hospital which is affiliated with the Health Department of Guangdong Province in China. It was designated a national key clinical (cancer) hospital by the National Health and Family Planning Commission in 2011. The same year, Guangzhou Fuda Cancer Hospital was honored with National Trustworthy Private Hospital by the National Institute of Hospital Administration. In 2012, China Hospital Association rated Guangzhou Fuda Cancer Hospital as China Public Confidence Model Hospital. It was accredited by JCI in 2014.

Shanghai MicroPort Cardiovascular Technology (Group) Co., Ltd., established on 2012-08-17, The business scope includes the production of Class III6846bracket,Class III6877intravascular catheter,Sell ​​self-produced products;R&D aorta,Peripheral Vascular Interventional Therapy Medical Devices,Transfer of self-developed technology,And provide related technical services,technical consulting;engaged in medical equipment(Class I,Class II,Class III)Wholesale,import and export,commission agent(except auction),and provide related services(Does not involve state trade management,Quota involved,of license-managed goods,Apply in accordance with relevant national regulations).[Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Hunan Lingkang Medical Technology Co., Ltd., established on 2015-08-12, The scope of business includes a class of medical devices,Class II medical device,Production of Class III Medical Devices;Class I medical device,Class II medical device,Sales of Class III Medical Devices;Self-operated and agent import and export of various commodities and technologies,Except for the goods and technologies that the state restricts the company to operate or prohibits the import and export of.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Wuhan Yangsen Biotechnology is a technology company that focuses on research and development, production and sales of medical devices. Their product such as three-layer bionic structure artificial blood vessel that is designed with reference to the human body's own arterial structure, which greatly optimizes the artificial blood vessel product.

Annexin Pharmaceuticals AB (publ) is a world-leading biotechnology company within the Annexin A5 area, for the treatment of various cardiovascular diseases. The company's biological drug candidate ANXV - a human recombinant protein, Annexin A5 - is primarily intended for acute treatment of patients with cardiovascular diseases with injuries and inflammation in the blood vessels. In addition, the company has an extensive patent portfolio for the treatment of diseases that arise due to damage and inflammation of the blood vessels. Annexin Pharmaceuticals has established and optimized a cell line for large-scale manufacturing of Annexin A5. The production process is patent-pending. ANXV has the ability to protect and repair the blood vessels and to counteract the inflammation. Thus, ANXV is expected to reduce suffering and hopefully mortality for several patient groups with both rare vascular diseases and major diseases such as heart attack. ANXV has the potential to become First-In-Class (product with new unique mechanisms of action that is the first of its kind in the market) for several patient groups where there are large unmet medical treatment needs.

Cornell provides education about the earth and atmospheric sciences. They offer summer and winter sessions. Their students contact them through phone and email services.

Peking Union Medical College Hospital, also known as Beijing Xiehe Hospital (Chinese: 北京协和医院), is a renowned general hospital in Beijing, China. It was founded in 1921 by Rockefeller Foundation and is affiliated to both Peking Union Medical College (PUMC) and Chinese Academy of Medical Sciences (CAMS). During the Cultural Revolution, it was renamed the "Anti-imperialist Hospital".